Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration
Journal of Veterinary Pharmacology and Therapeutics · 2024
DOI: 10.1111/jvp.13412 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, 2024. Verfasst von Annemari Jokela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Thiazines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Finnish Foundation of Veterinary Research, The Finnish Veterinary Foundation, Juliana von Wendt Foundation.
Abstract (Originalsprache)
Meloxicam is routinely used for pain alleviation in pre‐ruminant calves during husbandry procedures. The pharmacokinetics of a single dose (0.5 mg/kg) of meloxicam was investigated after intravenous (IV), subcutaneous (SC), and oral (PO) administration in 30 pre‐ruminant calves. Each group included 10 calves. Oral meloxicam was administered at least 1 h after feeding. Plasma samples were collected for up to 168 h, and the meloxicam concentration was analysed with liquid chromatography and mass spectrometry, followed by a noncompartmental pharmacokinetic analysis. The maximum meloxicam concentrations in plasma were 1.91 ± 0.27 μg/mL and 1.77 ± 0.16 μg/mL after SC and PO routes, respectively. The time of maximum concentration was 7.6 ± 2.8 h after SC and 10.0 ± 5.7 h after PO administration. The approximate bioavailability of meloxicam was 97% for SC and PO routes. The elimination half‐lives were 79.2 ± 12.4, 84.6 ± 24.8, and 84.8 ± 22.3 h after IV, SC, and PO routes, respectively. The results suggest that the therapeutic meloxicam concentrations in plasma that are required for pain relief in other species, such as horses, may be maintained for several days following a single dose (0.5 mg/kg) administered IV, SC, or PO in calves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
- Research Centre for Animal Welfare, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
- Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
- Pharmacology Department, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt.
ORCID-Profile: Annemari Jokela, Magdy Adam, Kati Salla, Marja Raekallio, Riikka Aho, Marianna Norring, Ann-Helena Hokkanen
Förderung
- Finnish Foundation of Veterinary Research
- The Finnish Veterinary Foundation
- Juliana von Wendt Foundation
- Vetcare Finland Ltd.
- Walter Ehrström Foundation
- Suomen Eläinlääketieteen Säätiö
- Juliana von Wendtin Säätiö
- Walter Ehrströmin Säätiö
Zitieren
APA
Jokela, A., Nyrhilä, A., Adam, M., Salla, K., Raekallio, M., Aho, R., Norring, M., & Hokkanen, A. H. (2024). Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics. https://doi.org/10.1111/jvp.13412
Vancouver
Jokela A, Nyrhilä A, Adam M, Salla K, Raekallio M, Aho R, et al. Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration. Journal of Veterinary Pharmacology and Therapeutics. 2024. doi:10.1111/jvp.13412
BibTeX
@article{Jokela2024,
author = {Jokela, Annemari and Nyrhilä, Alexandra and Adam, Magdy and Salla, Kati and Raekallio, Marja and Aho, Riikka and Norring, Marianna and Hokkanen, Ann-Helena},
title = {Pharmacokinetics of meloxicam in pre‐ruminant calves after intravenous, oral, and subcutaneous administration},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2024},
doi = {10.1111/jvp.13412}
}
EUVIMED